Buscar resultados de ensayos clínicos
Azotemia - 25 Studies Found
Estado | Estudiar |
Terminated |
Nombre del estudio: Complement Inhibition in aHUS Dialysis Patients Condición: Atypical Hemolytic Uremic Syndrome Fecha: 2015-05-26 Intervenciones: Drug: CCX168 |
Completed |
Nombre del estudio: A Retrospective, Observational, Non-interventional Trial to Assess Eculizumab Treatment Effect in Patients With Atypical Hemolytic Uremic Syndrome (aHUS) Condición: Atypical Hemolytic Uremic Syndrome (aHUS) Fecha: 2012-11-13 |
Completed |
Nombre del estudio: The Safety and Efficacy of Eculizumab in Japanese Patients With Atypical Hemolytic Uremic Syndrome (aHUS) Condición: Atypical Hemolytic Uremic Syndrome (aHUS) Fecha: 2012-12-04 Intervenciones: Drug: Eculizumab |
Completed |
Nombre del estudio: To Characterize the Safety and Tolerability of Eculizumab in Two Japanese aHUS Patients Condición: ATYPICAL HEMOLYTIC UREMIC SYNDROME (AHUS) Fecha: 2012-12-04 |
Recruiting |
Nombre del estudio: Atypcial Hemolytic-Uremic Syndrome (aHUS) Registry Condición: Atypical Hemolytic-Uremic Syndrome Fecha: 2012-01-18 |
Terminated |
Nombre del estudio: aHUS Observational Long Term Follow-Up Condición: Atypical Hemolytic Uremic Syndrome Fecha: 2012-01-18 |
Completed |
Nombre del estudio: An Open-label, Multi-center Clinical Trial of Eculizumab in Adult Patients With Atypical Hemolytic-uremic Syndrome Condición: Atypical Hemolytic-Uremic Syndrome Fecha: 2010-08-31 Intervenciones: Drug: Eculizumab All patients received open-label eculizumab administered intravenously on the following |
Completed |
Nombre del estudio: An Open-Label, Multi-Center Clinical Trial of Eculizumab in Pediatric Patients With Atypical Hemolytic-Uremic Syndrome Condición: Atypical Hemolytic-Uremic Syndrome Fecha: 2010-08-31 Intervenciones: Drug: Eculizumab Fixed dosing is based on body weight cohorts. Adjustment of dose to accommodate patient |
Completed |
Nombre del estudio: Open Label Controlled Trial of Eculizumab in Adolescent Patients With Plasma Therapy-Resistant aHUS Condición: Atypical Hemolytic Uremic Syndrome Fecha: 2009-02-13 Intervenciones: Drug: Eculizumab All patients received open-label eculizumab administered intravenously on the following |
Completed |
Nombre del estudio: Open Label Controlled Trial of Eculizumab in Adult Patients With Plasma Therapy-Resistant aHUS Condición: Atypical Hemolytic Uremic Syndrome Fecha: 2009-02-13 Intervenciones: Drug: Eculizumab All patients received open-label eculizumab administered intravenously on the following |